Exenatide is a glucagon-like peptide-1 agonist (GLP-1 agonist) medication,
belonging to the group of incretin mimetics, approved in April 2005 for the
Jun 15, 2016 ... Exenatide injection may increase the risk that you will develop tumors of the
thyroid gland, including medullary thyroid carcinoma (MTC; a type ...
Dec 19, 2014 ... DRUG CLASS AND MECHANISM: Exenatide is an injectable drug that reduces
the level of sugar (glucose) in the blood. It is used for treating ...
BYETTA (exenatide) is a synthetic peptide that was originally identified in the
lizard Heloderma suspectum. Exenatide differs in chemical structure and ...
Following a standardized meal, BYETTA<sup>®</sup> (exenatide) injection reduced elevated
PPG excursions to a nearly flat profile in patients with type 2 diabetes.
Exenatide is an antidiabetic injection that is used in treating type 2 diabetes.
Read more about diabetes treatments and antidiabetic injections at Patient.
Easy to read patient leaflet for exenatide. Includes indications, proper use,
special instructions, precautions, and possible side effects.
May 4, 2005 ... The FDA has approved this incretin mimetic as adjunctive therapy in patients with
type 2 diabetes who have not achieved adequate control with ...
Byetta (exenatide): For the adjunctive treatment of Type 2 diabetes mellitus. New
approved drug details including side effects, uses and general information.
Byetta (generic name Exenatide) is used to treat people with type 2 diabetes.
Byetta is an injectable drug that helps to lower blood sugar levels in a way that ...